NO306952B1 - Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasoeytiske blandinger som inneholder dem - Google Patents

Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasoeytiske blandinger som inneholder dem

Info

Publication number
NO306952B1
NO306952B1 NO941686A NO941686A NO306952B1 NO 306952 B1 NO306952 B1 NO 306952B1 NO 941686 A NO941686 A NO 941686A NO 941686 A NO941686 A NO 941686A NO 306952 B1 NO306952 B1 NO 306952B1
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
heparin fractions
purified heparin
Prior art date
Application number
NO941686A
Other languages
English (en)
Norwegian (no)
Other versions
NO941686D0 (no
NO941686L (no
Inventor
Jean-Francois Branellec
Jose Espejo
Philippe Picart
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9446915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO306952(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choay Sa filed Critical Choay Sa
Publication of NO941686D0 publication Critical patent/NO941686D0/no
Publication of NO941686L publication Critical patent/NO941686L/no
Publication of NO306952B1 publication Critical patent/NO306952B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO941686A 1993-05-07 1994-05-06 Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasoeytiske blandinger som inneholder dem NO306952B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305534A FR2704861B1 (fr) 1993-05-07 1993-05-07 Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Publications (3)

Publication Number Publication Date
NO941686D0 NO941686D0 (no) 1994-05-06
NO941686L NO941686L (no) 1994-11-08
NO306952B1 true NO306952B1 (no) 2000-01-17

Family

ID=9446915

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941686A NO306952B1 (no) 1993-05-07 1994-05-06 Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasoeytiske blandinger som inneholder dem

Country Status (26)

Country Link
US (1) US5599801A (da)
EP (1) EP0623629B1 (da)
JP (1) JP3529835B2 (da)
KR (1) KR100328095B1 (da)
CN (1) CN1066155C (da)
AT (1) ATE141618T1 (da)
AU (1) AU672291B2 (da)
BR (1) BR9401920A (da)
CA (1) CA2122930C (da)
CZ (1) CZ287889B6 (da)
DE (1) DE69400385T2 (da)
DK (1) DK0623629T3 (da)
ES (1) ES2093494T3 (da)
FI (1) FI107388B (da)
FR (1) FR2704861B1 (da)
GR (1) GR3021648T3 (da)
HK (1) HK1007432A1 (da)
HU (1) HU221595B (da)
IL (1) IL109587A (da)
MY (1) MY110862A (da)
NO (1) NO306952B1 (da)
NZ (1) NZ260460A (da)
PL (1) PL178294B1 (da)
RU (1) RU2133253C1 (da)
TW (1) TW438812B (da)
ZA (1) ZA943152B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
CA2235223A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
EP1109919A2 (en) * 1998-08-27 2001-06-27 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
JP4824170B2 (ja) * 1999-04-23 2011-11-30 マサチューセッツ インスティテュート オブ テクノロジー ポリマーを表記するためのシステムおよび方法
WO2001066772A2 (en) * 2000-03-08 2001-09-13 Massachusetts Institute Of Technology Heparinase iii and uses thereof
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
DE60138115D1 (de) 2000-09-12 2009-05-07 Massachusetts Inst Technology Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
US7709461B2 (en) * 2000-10-18 2010-05-04 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
JP2002293804A (ja) * 2001-03-28 2002-10-09 Itoham Foods Inc 低分子量ヘパリンの製造法
EP1518120A4 (en) * 2002-03-11 2008-08-13 Momenta Pharmaceuticals Inc ANALYSIS OF SULFATE POLYSACCHARIDES
RU2248801C2 (ru) * 2003-04-21 2005-03-27 ГУ Гематологический научный центр РАМН Способ получения низкомолекулярных гепаринов
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
RU2295538C2 (ru) * 2005-03-01 2007-03-20 Гематологический научный центр РАМН Способ получения гепаринов с низкой молекулярной массой
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2817779T3 (es) * 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
CA2974062C (en) * 2010-09-14 2018-07-17 Fuso Pharmaceutical Industries, Ltd. High purity heparin and production method therefor
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102633905B (zh) * 2011-04-11 2014-10-08 南通天龙畜产品有限公司 一种肝素钠中不被亚硝酸降解且在肝素钠保留时间附近出峰的物质的去除方法
CN104045744B (zh) * 2014-06-26 2016-01-06 常州千红生化制药股份有限公司 达肝素钠的制备方法
CN104098716B (zh) * 2014-07-16 2015-04-22 南京健友生化制药股份有限公司 一种达肝素钠精品的生产方法
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105294885A (zh) * 2015-11-23 2016-02-03 山东大学 一种新来源亚硝酸降解低分子肝素的制备方法
EP3740513B1 (en) * 2018-02-14 2022-06-22 Biological E Limited Improved process for the preparation of dalteparin sodium
RU186728U1 (ru) * 2018-10-19 2019-01-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" Лабораторное устройство для отмывки порошковых продуктов химических реакций от посторонних примесей
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CA3144968A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides
CN110845641A (zh) * 2019-11-07 2020-02-28 中国药科大学 一种肝素寡糖及其在制备抗血管生成药物中的应用
CN110787489A (zh) * 2019-11-20 2020-02-14 江苏千牧生物科技股份有限公司 一种肝素钠加工使用的分离装置及加工的工艺
CN115304688A (zh) * 2022-08-25 2022-11-08 湖北亿诺瑞生物制药有限公司 一种达肝素钠的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119774A (en) * 1976-03-05 1978-10-10 Ab Kabi Heparin purification method
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
US4438261A (en) * 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
FR2538404B1 (da) * 1982-12-28 1985-08-23 Anic Spa
FR2568774B2 (fr) * 1984-05-30 1989-05-19 Choay Sa Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique
US5094815A (en) * 1988-05-18 1992-03-10 Cornell Research Foundation, Inc. Photolytic interface for HPLC-chemiluminescence detection of non volatile N-nitroso compounds
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia

Also Published As

Publication number Publication date
FI107388B (fi) 2001-07-31
TW438812B (en) 2001-06-07
FI942095A0 (fi) 1994-05-06
KR100328095B1 (ko) 2002-06-20
JPH07126302A (ja) 1995-05-16
NZ260460A (en) 1996-02-27
HU9401446D0 (en) 1994-08-29
CA2122930C (en) 2000-10-24
DK0623629T3 (da) 1996-12-23
HUT70553A (en) 1995-10-30
BR9401920A (pt) 1994-11-29
RU2133253C1 (ru) 1999-07-20
DE69400385T2 (de) 1996-12-19
ZA943152B (en) 1995-01-09
CZ113294A3 (en) 1994-12-15
MY110862A (en) 1999-05-31
ES2093494T3 (es) 1996-12-16
CN1096034A (zh) 1994-12-07
FR2704861B1 (fr) 1995-07-28
CN1066155C (zh) 2001-05-23
ATE141618T1 (de) 1996-09-15
FI942095L (fi) 1994-11-08
IL109587A (en) 1997-04-15
AU6191294A (en) 1994-11-10
JP3529835B2 (ja) 2004-05-24
AU672291B2 (en) 1996-09-26
NO941686D0 (no) 1994-05-06
EP0623629A1 (fr) 1994-11-09
US5599801A (en) 1997-02-04
CZ287889B6 (cs) 2001-03-14
HK1007432A1 (en) 1999-04-09
DE69400385D1 (de) 1996-09-26
HU221595B (hu) 2002-11-28
EP0623629B1 (fr) 1996-08-21
IL109587A0 (en) 1994-08-26
PL178294B1 (pl) 2000-04-28
RU94015595A (ru) 1996-09-27
GR3021648T3 (en) 1997-02-28
CA2122930A1 (en) 1994-11-08
NO941686L (no) 1994-11-08
FR2704861A1 (fr) 1994-11-10

Similar Documents

Publication Publication Date Title
NO941686L (no) Rensede heparinfraksjoner, fremgangsmåte ved fremstilling derav og farmasöytiske blandinger som inneholder dem
DE69315724D1 (de) Polysaccharidderivate von Heparin, Heparansulfate, ihre Fraktionen und Fragmente, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, welche diese enthalten
BR9603514A (pt) Processo para melhorar a absorção de radiação uv de uma composição
ES2081458T3 (es) Composicion de pintura.
DE69027440D1 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
HUP9902287A1 (hu) Szintetikus poliszacharidok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
PT98481A (pt) Processo para a preparacao de clatratos de peroxiacidos
AU3793195A (en) Cinnamic acid derivatives
BR8804367A (pt) Um composto de triazina substituida por arilenodiamino,um processo para fabricar o dito composto,uma composicao resistente a degradacao e um artigo de borracha resistente ao ozonio feito empregando o dito composto
DE59300176D1 (de) 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
ES8604623A1 (es) Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii
NO975466L (no) Amorf, farget plate av en krystalliserbar termoplast
ATE150468T1 (de) Dermatansulfatoligosaccharide, verfahren zu ihrer herstellung und diese enthaltende phamazeutische zusammensetzungen
DE69013305D1 (de) Stabile form von cephradin, verfahren zu dessen herstellung und darin verwendete zwischenprodukte.
AR014447A1 (es) Procedimiento para el procesamiento de corcho y tapones de corcho
FI925745A0 (fi) Interleukin-6-kompositioner och foerfarande foer deras framstaellning
IT1256236B (it) Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
EP0828258A3 (en) Dielectric fluids
BR9101438A (pt) Processo para preparacao de resina,bem como dispersao aquosa
AU1162592A (en) Low-molecular sulphated poly-beta -2,6-fructofuranosanes and their use in the treatment of degenerative articular ailments
ITMI920437A1 (it) Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
IT8821627A0 (it) Alcossiimmine fluorurate e loro n-cloro ed n-bromo derivati e processo per la loro preparazione.
PT89500A (pt) Processo para a preparacao de derivados de tetra-hidropiridina e de composicoes farmaceuticas que os contem
PT93822A (pt) Processo para a preparacao de derivados de piridina
ITRM920631A1 (it) Processo chimico industriale e relativo impianto per la decomposizione e demilitarizzazione della miscela di aggressivi chimici: iprite e fenildicloro arsina.

Legal Events

Date Code Title Description
MK1K Patent expired